Summary
- Medical Properties Trust’s management argues that the company’s shares are undervalued and presents data supporting this claim.
- The company’s net leverage ratio is higher than its peers, but not significantly so, suggesting that it may deserve to trade at a modest discount.
- Despite concerns about distribution coverage, the overall analysis indicates that the company’s shares are undervalued, making it a strong buy.